MedPath

Prospective study into submicroscopic chromosomal abnormalities in foetuses with structural malformations on ultrasound

Conditions
small DNA defects
10016849
submicroscopic chromosomal abnormalities of the subtelomeres
Registration Number
NL-OMON30792
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
130
Inclusion Criteria

Only if amniocentesis is already planned because of abnormal ultrasonographic findings of the fetus, future parents will be asked for this study.
The MLPA-test will only be performed if the karyotyping is normal.

Exclusion Criteria

Abnormal fetal karyotype that can explain the ultrasonographic anomalies.
Absence of a signed informed consent by both parents.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The overall percentage of submicroscopic chromosomal abnormalities(<br /><br>microdeletions or -duplications) in fetuses with structural malformations and a<br /><br>normal routine karyotyping</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1 Percentage of relevant submicroscopic chromosomal abnormalities<br /><br>with known clinical implications versus the percentage of unknown abnormalities<br /><br>with unclear clinical implications in fetuses with structural malformations and<br /><br>normal routine karyotyping?<br /><br>2. Can we ascertain an association between the fetal malformation and the<br /><br>detected submicroscopic chromosomal abnormality? </p><br>
© Copyright 2025. All Rights Reserved by MedPath